XML 73 R59.htm IDEA: XBRL DOCUMENT v3.8.0.1
Guarantor Financial Information (Tables)
12 Months Ended
Dec. 31, 2017
Condensed Financial Information of Parent Company Only Disclosure [Abstract]  
Condensed consolidating balance sheet
 
December 31, 2017
Condensed Consolidating Balance Sheet
(U.S. dollars in thousands)
XL-Group (1)
 
XLIT
 
Other XL-Group Subsidiaries
 
Consolidating Adjustments and Eliminations
 
XL-Group Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
Investments:
 
 
 
 
 
 
 
 
 

Total investments available for sale
$

 
$
528,152

 
$
31,930,284

 
$

 
$
32,458,436

Total investments trading

 

 
2,021,350

 

 
2,021,350

Investments in affiliates

 

 
1,911,996

 

 
1,911,996

Other investments

 

 
1,163,863

 

 
1,163,863

Total investments
$

 
$
528,152

 
$
37,027,493

 
$

 
$
37,555,645

Cash and cash equivalents
3,950

 
158,688

 
3,273,316

 

 
3,435,954

Restricted cash

 

 
157,497

 

 
157,497

Investments in subsidiaries
9,817,979

 
13,379,083

 

 
(23,197,062
)
 

Accrued investment income
11

 
2,436

 
269,702

 

 
272,149

Deferred acquisition costs and value of business acquired

 

 
1,102,474

 

 
1,102,474

Ceded unearned premiums

 

 
2,198,217

 

 
2,198,217

Premiums receivable

 

 
6,934,482

 

 
6,934,482

Reinsurance balances receivable

 

 
930,114

 

 
930,114

Unpaid losses and loss expenses recoverable

 

 
7,247,723

 

 
7,247,723

Receivable from investments sold

 

 
201,515

 

 
201,515

Goodwill and other intangible assets

 

 
2,225,751

 

 
2,225,751

Deferred tax asset

 

 
332,024

 

 
332,024

Amounts due from subsidiaries/parent
32,301

 

 
61,976

 
(94,277
)
 

Other assets
14,541

 
27,244

 
800,906

 

 
842,691

Total assets
$
9,868,782

 
$
14,095,603

 
$
62,763,190

 
$
(23,291,339
)
 
$
63,436,236

 
 
 
 
 
 
 
 
 
 
LIABILITIES AND SHAREHOLDERS' EQUITY
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 

Unpaid losses and loss expenses
$

 
$

 
$
29,696,779

 
$

 
$
29,696,779

Deposit liabilities

 

 
1,042,677

 

 
1,042,677

Future policy benefit reserves

 

 
3,610,926

 

 
3,610,926

Funds withheld on GreyCastle life retrocession arrangements

 

 
999,219

 

 
999,219

Unearned premiums

 

 
8,307,431

 

 
8,307,431

Notes payable and debt

 
3,220,769

 

 

 
3,220,769

Reinsurance balances payable

 

 
3,706,116

 

 
3,706,116

Payable for investments purchased

 
848

 
332,141

 

 
332,989

Deferred tax liability

 

 
57,574

 

 
57,574

Amounts due to subsidiaries/parent

 
62,111

 
32,166

 
(94,277
)
 

Other liabilities
20,465

 
36,975

 
942,996

 

 
1,000,436

Total liabilities
$
20,465

 
$
3,320,703

 
$
48,728,025

 
$
(94,277
)
 
$
51,974,916

 
 
 
 
 
 
 
 
 
 
Shareholders' Equity:
 
 
 
 
 
 
 
 
 

Shareholders' equity attributable to XL Group Ltd
$
9,848,317

 
$
9,817,979

 
$
13,379,083

 
$
(23,197,062
)
 
$
9,848,317

Non-controlling interest in equity of consolidated subsidiaries

 
956,921

 
656,082

 

 
1,613,003

Total shareholders' equity
$
9,848,317

 
$
10,774,900

 
$
14,035,165

 
$
(23,197,062
)
 
$
11,461,320

Total liabilities and shareholders' equity
$
9,868,782

 
$
14,095,603

 
$
62,763,190

 
$
(23,291,339
)
 
$
63,436,236

____________
(1)
Results for the period include XL-Ireland, which prior to the Redomestication was the ultimate parent and is now in liquidation proceedings as outlined in Note 1, "Significant Accounting Policies." The Company expects the net assets of XL-Ireland to ultimately be distributed to XL Group upon completion of the liquidation.
 
December 31, 2016
Condensed Consolidating Balance Sheet
(U.S. dollars in thousands, except share data)
XL-Group (1)
 
XLIT
 
Other XL-Group Subsidiaries
 
Consolidating Adjustments and Eliminations
 
XL-Group Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
Investments:
 
 
 
 
 
 
 
 
 

Total investments available for sale
$

 
$
638,236

 
$
31,280,890

 
$

 
$
31,919,126

Total investments trading

 

 
1,626,577

 

 
1,626,577

Investments in affiliates

 

 
2,177,645

 

 
2,177,645

Other investments

 
9

 
1,164,555

 

 
1,164,564

Total investments
$

 
$
638,245

 
$
36,249,667

 
$

 
$
36,887,912

Cash and cash equivalents
1,022

 
84,286

 
3,341,680

 

 
3,426,988

Restricted cash

 

 
153,504

 

 
153,504

Investments in subsidiaries
10,897,195

 
14,238,698

 

 
(25,135,893
)
 

Accrued investment income
55

 
2,981

 
281,385

 
(55
)
 
284,366

Deferred acquisition costs and value of business acquired

 

 
946,721

 

 
946,721

Ceded unearned premiums

 

 
1,687,864

 

 
1,687,864

Premiums receivable

 

 
5,522,976

 

 
5,522,976

Reinsurance balances receivable

 

 
577,479

 

 
577,479

Unpaid losses and loss expenses recoverable

 

 
5,491,297

 

 
5,491,297

Receivable from investments sold

 

 
128,411

 

 
128,411

Goodwill and other intangible assets

 

 
2,203,653

 

 
2,203,653

Deferred tax asset

 

 
310,542

 

 
310,542

Amounts due from subsidiaries/parent
42,780

 

 
72,962

 
(115,742
)
 

Other assets
15,188

 
40,108

 
757,093

 

 
812,389

Total assets
$
10,956,240

 
$
15,004,318

 
$
57,725,234

 
$
(25,251,690
)
 
$
58,434,102

 
 
 
 
 
 
 
 
 
 
LIABILITIES AND SHAREHOLDERS' EQUITY
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 

Unpaid losses and loss expenses
$

 
$

 
$
25,939,571

 
$

 
$
25,939,571

Deposit liabilities

 

 
1,116,233

 

 
1,116,233

Future policy benefit reserves

 

 
3,506,047

 

 
3,506,047

Funds withheld on GreyCastle life retrocession arrangements

 

 
998,968

 

 
998,968

Unearned premiums

 

 
7,293,028

 

 
7,293,028

Notes payable and debt

 
2,647,677

 

 

 
2,647,677

Reinsurance balances payable

 

 
2,451,717

 

 
2,451,717

Payable for investments purchased

 

 
226,009

 

 
226,009

Deferred tax liability

 

 
77,271

 

 
77,271

Amounts due to subsidiaries/parent

 
72,962

 
42,780

 
(115,742
)
 

Other liabilities
17,728

 
41,984

 
1,157,190

 

 
1,216,902

Total liabilities
$
17,728

 
$
2,762,623

 
$
42,808,814

 
$
(115,742
)
 
$
45,473,423

 
 
 
 
 
 
 
 
 
 
Shareholders' Equity:
 
 
 
 
 
 
 
 
 

Shareholders' equity attributable to XL Group Ltd
$
10,938,512

 
$
10,897,195

 
$
14,238,698

 
$
(25,135,893
)
 
$
10,938,512

Non-controlling interest in equity of consolidated subsidiaries

 
1,344,500

 
677,722

 
(55
)
 
2,022,167

Total shareholders' equity
$
10,938,512

 
$
12,241,695

 
$
14,916,420

 
$
(25,135,948
)
 
$
12,960,679

Total liabilities and shareholders' equity
$
10,956,240

 
$
15,004,318

 
$
57,725,234

 
$
(25,251,690
)
 
$
58,434,102


____________
(1)
Results for the period include XL-Ireland, which prior to the Redomestication was the ultimate parent and is now in liquidation proceedings as outlined in Note 1, "Significant Accounting Policies." The Company expects the net assets of XL-Ireland to ultimately be distributed to XL Group upon completion of the liquidation.
Condensed consolidating statement of income and comprehensive income
 
Year Ended December 31, 2017
Condensed Consolidating Statements of Income and Comprehensive Income
(U.S. dollars in thousands)
XL-Group (1)
 
XLIT
 
Other XL-Group Subsidiaries
 
Consolidating Adjustments and Eliminations
 
XL-Group Consolidated
Revenues:
 
 
 
 
 
 
 
 
 
Net premiums earned
$

 
$

 
$
10,336,612

 
$

 
$
10,336,612

Total net investment income
160

 
9,822

 
819,873

 
(132
)
 
829,723

Total net realized gains (losses) on investments
(239
)
 
701

 
221,175

 
239

 
221,876

Net realized and unrealized gains (losses) on derivative instruments

 

 
(41,732
)
 

 
(41,732
)
Net realized and unrealized gains (losses) on life retrocession embedded derivative and derivative instruments - Life Funds Withheld Assets

 

 
(206,015
)
 

 
(206,015
)
Income (loss) from investment affiliates

 

 
139,046

 

 
139,046

Fee income and other

 

 
48,647

 

 
48,647

Total revenues
$
(79
)
 
$
10,523

 
$
11,317,606

 
$
107

 
$
11,328,157

Expenses:
 
 
 
 
 
 
 
 
 
Net losses and loss expenses incurred
$

 
$

 
$
8,001,920

 
$

 
$
8,001,920

Claims and policy benefits

 

 
39,189

 

 
39,189

Acquisition costs

 

 
1,788,140

 

 
1,788,140

Operating expenses
63,307

 
2,283

 
1,691,469

 

 
1,757,059

Foreign exchange (gains) losses
2,026

 
7,136

 
35,458

 

 
44,620

(Gain) loss from the early extinguishment of debt

 
1,582

 

 

 
1,582

Interest expense

 
150,314

 
40,045

 

 
190,359

Total expenses
$
65,333

 
$
161,315

 
$
11,596,221

 
$

 
$
11,822,869

Income (loss) before income tax and income (loss) from operating affiliates
$
(65,412
)
 
$
(150,792
)
 
$
(278,615
)
 
$
107

 
$
(494,712
)
Income (loss) from operating affiliates

 

 
63,645

 

 
63,645

Equity in net earnings (losses) of subsidiaries
(494,986
)
 
(304,355
)
 

 
799,341

 

Provision (benefit) for income tax

 

 
59,070

 

 
59,070

Net income (loss)
$
(560,398
)
 
$
(455,147
)
 
$
(274,040
)
 
$
799,448

 
$
(490,137
)
Non-controlling interests

 
39,839

 
30,315

 
107

 
70,261

Net income (loss) attributable to common shareholders
$
(560,398
)
 
$
(494,986
)
 
$
(304,355
)
 
$
799,341

 
$
(560,398
)
 
 
 
 
 
 
 
 
 
 
Comprehensive income (loss)
$
(386,513
)
 
$
(321,101
)
 
$
(130,470
)
 
$
451,571

 
$
(386,513
)
____________
(1)
Results for the period include XL-Ireland, which prior to the Redomestication was the ultimate parent and is now in liquidation proceedings as outlined in Note 1, "Significant Accounting Policies." The Company expects the net assets of XL-Ireland to ultimately be distributed to XL Group upon completion of the liquidation.
 
Year Ended December 31, 2016
Condensed Consolidating Statements of Income and Comprehensive Income
(U.S. dollars in thousands, except per share data)
XL-Group (1)
 
XLIT
 
Other XL-Group Subsidiaries
 
Consolidating Adjustments and Eliminations
 
XL-Group Consolidated
Revenues:
 
 
 
 
 
 
 
 
 
Net premiums earned
$

 
$

 
$
9,777,934

 
$

 
$
9,777,934

Total net investment income
436

 
9,135

 
817,998

 
(436
)
 
827,133

Total net realized gains (losses) on investments

 
1,918

 
370,220

 

 
372,138

Net realized and unrealized gains (losses) on derivative instruments

 

 
2,521

 

 
2,521

Net realized and unrealized gains (losses) on life retrocession embedded derivative and derivative instruments - Life Funds Withheld Assets

 

 
(540,090
)
 

 
(540,090
)
Income (loss) from investment affiliates

 

 
70,758

 

 
70,758

Fee income and other

 

 
35,692

 

 
35,692

Total revenues
$
436

 
$
11,053

 
$
10,535,033

 
$
(436
)
 
$
10,546,086

Expenses:
 
 
 
 
 
 
 
 
 
Net losses and loss expenses incurred
$

 
$

 
$
6,072,835

 
$

 
$
6,072,835

Claims and policy benefits

 

 
28,244

 

 
28,244

Acquisition costs

 

 
1,620,671

 

 
1,620,671

Operating expenses
93,247

 
4,985

 
1,965,130

 

 
2,063,362

Foreign exchange (gains) losses
(1,106
)
 
(343
)
 
(8,129
)
 

 
(9,578
)
(Gain) Loss on sale of subsidiary

 

 
(7,088
)
 

 
(7,088
)
Interest expense
(4
)
 
140,644

 
69,123

 

 
209,763

Total expenses
$
92,137

 
$
145,286

 
$
9,740,786

 
$

 
$
9,978,209

Income (loss) before income tax and income (loss) from operating affiliates
$
(91,701
)
 
$
(134,233
)
 
$
794,247

 
$
(436
)
 
$
567,877

Income (loss) from operating affiliates

 

 
44,397

 

 
44,397

Equity in net earnings (losses) of subsidiaries
532,049

 
744,877

 

 
(1,276,926
)
 

Provision (benefit) for income tax
(620
)
 

 
42,749

 

 
42,129

Net income (loss)
$
440,968

 
$
610,644

 
$
795,895

 
$
(1,277,362
)
 
$
570,145

Non-controlling interests

 
78,595

 
51,018

 
(436
)
 
129,177

Net income (loss) attributable to common shareholders
$
440,968

 
$
532,049

 
$
744,877

 
$
(1,276,926
)
 
$
440,968

 
 
 
 
 
 
 
 
 
 
Comprehensive income (loss)
$
469,898

 
$
560,979

 
$
773,807

 
$
(1,334,786
)
 
$
469,898

____________
(1)
Results for the period include XL-Ireland, which prior to the Redomestication was the ultimate parent and is now in liquidation proceedings as outlined in Note 1, "Significant Accounting Policies." The Company expects the net assets of XL-Ireland to ultimately be distributed to XL Group upon completion of the liquidation.

 
Year Ended December 31, 2015
Condensed Consolidating Statements of Income and Comprehensive Income
(U.S. dollars in thousands, except per share data)
XL- Ireland
 
XLIT
 
Other XL-Ireland Subsidiaries
 
Consolidating Adjustments and Eliminations
 
XL-Ireland Consolidated
Revenues:
 
 
 
 
 
 
 
 
 
Net premiums earned
$

 
$

 
$
8,226,425

 
$

 
$
8,226,425

Total net investment income
169

 
9,363

 
859,002

 
3,836

 
872,370

Total net realized gains (losses) on investments

 
13,814

 
197,129

 
(8,765
)
 
202,178

Net realized and unrealized gains (losses) on derivative instruments

 
12,363

 
40,760

 

 
53,123

Net realized and unrealized gains (losses) on life retrocession embedded derivative and derivative instruments - Life Funds Withheld Assets

 

 
(151,691
)
 

 
(151,691
)
Income (loss) from investment affiliates

 

 
73,320

 

 
73,320

Fee income and other

 

 
33,201

 

 
33,201

Total revenues
$
169

 
$
35,540

 
$
9,278,146

 
$
(4,929
)
 
$
9,308,926

Expenses:
 
 
 
 
 
 
 
 
 
Net losses and loss expenses incurred
$

 
$

 
$
4,766,200

 
$

 
$
4,766,200

Claims and policy benefits

 

 
115,997

 

 
115,997

Acquisition costs

 

 
1,317,448

 

 
1,317,448

Operating expenses
46,340

 
10,565

 
1,910,034

 

 
1,966,939

Foreign exchange (gains) losses
(345
)
 
20

 
22,829

 

 
22,504

(Gain) loss from the early extinguishment of debt


 

 
5,592

 

 
5,592

Interest expense
11

 
143,330

 
61,874

 

 
205,215

Total expenses
$
46,006

 
$
153,915

 
$
8,199,974

 
$

 
$
8,399,895

Income (loss) before income tax and income (loss) from operating affiliates
$
(45,837
)
 
$
(118,375
)
 
$
1,078,172

 
$
(4,929
)
 
$
909,031

Income (loss) from operating affiliates

 

 
44,740

 

 
44,740

Gain on sale of operating affiliate

 

 
340,407

 

 
340,407

Equity in net earnings (losses) of subsidiaries
1,253,609

 
1,449,404

 

 
(2,703,013
)
 

Provision (benefit) for income tax
620

 
245

 
(20,026
)
 

 
(19,161
)
Net income (loss)
$
1,207,152

 
$
1,330,784

 
$
1,483,345

 
$
(2,707,942
)
 
$
1,313,339

Non-controlling interests

 
77,175

 
29,012

 

 
106,187

Net income (loss) attributable to common shareholders
$
1,207,152

 
$
1,253,609

 
$
1,454,333

 
$
(2,707,942
)
 
$
1,207,152

 
 
 
 
 
 
 
 
 
 
Comprehensive income (loss)
$
409,310

 
$
455,767

 
$
656,491

 
$
(1,112,258
)
 
$
409,310




Condensed consolidating statement of cash flows
 
Year Ended December 31, 2017
Condensed Consolidating Statement of Cash Flows
(U.S. dollars in thousands)
XL-Group (1)
 
XLIT
 
Other XL-Group Subsidiaries
 
Consolidating Adjustments and Eliminations
 
XL-Group Consolidated
Cash flows provided by (used in) operating activities:
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
$
284,709

 
$
618,263

 
$
176,821

 
$
(1,046,474
)
 
$
33,319

Cash flows provided by (used in) investing activities:
 
 
 
 
 
 
 
 
 
Proceeds from sale of fixed maturities and short-term investments
$

 
$
174,934

 
$
15,527,192

 
$

 
$
15,702,126

Proceeds from redemption of fixed maturities and short-term investments

 
137,658

 
3,332,838

 

 
3,470,496

Proceeds from sale of equity securities
5,253

 
45,680

 
756,872

 
(50,256
)
 
757,549

Purchases of fixed maturities and short-term investments

 
(208,395
)
 
(19,073,402
)
 

 
(19,281,797
)
Purchases of equity securities

 
(45,582
)
 
(326,610
)
 
45,582

 
(326,610
)
Proceeds from sale of affiliates

 

 
593,539

 

 
593,539

Purchases of affiliates

 

 
(176,034
)
 

 
(176,034
)
Returns of capital from subsidiaries
462,178

 

 

 
(462,178
)
 

Change in restricted cash

 

 
(3,993
)
 

 
(3,993
)
Other, net

 
1

 
(72,551
)
 

 
(72,550
)
Net cash provided by (used in) investing activities
$
467,431

 
$
104,296

 
$
557,851

 
$
(466,852
)
 
$
662,726

Cash flows provided by (used in) financing activities:
 
 
 
 
 
 
 
 
 
Proceeds from issuance of common shares and exercise of stock options
$
50,634

 
$

 
$

 
$

 
$
50,634

Buybacks of common shares
(571,614
)
 

 

 

 
(571,614
)
Repurchase of preference shares

 
(371,163
)
 
(45,003
)
 
4,674

 
(411,492
)
Employee withholding on share-based compensation

 

 
(24,189
)
 

 
(24,189
)
Dividends paid on common shares
(228,232
)
 
(295,987
)
 
(750,000
)
 
1,045,987

 
(228,232
)
Return of capital

 
(462,178
)
 

 
462,178

 

Distributions to non-controlling interests

 
(59,231
)
 
(65,561
)
 
487

 
(124,305
)
Contributions from non-controlling interests

 

 
59,583

 

 
59,583

Proceeds from issuance of debt

 
558,311

 

 

 
558,311

Repayment of debt

 
(17,909
)
 

 

 
(17,909
)
Deposit liabilities

 

 
(34,565
)
 

 
(34,565
)
Net cash provided by (used in) financing activities
$
(749,212
)
 
$
(648,157
)
 
$
(859,735
)
 
$
1,513,326

 
$
(743,778
)
Effects of exchange rate changes on foreign currency cash

 

 
56,699

 

 
56,699

Increase (decrease) in cash and cash equivalents
$
2,928

 
$
74,402

 
$
(68,364
)
 
$

 
$
8,966

Cash and cash equivalents – beginning of period
1,022

 
84,286

 
3,341,680

 

 
3,426,988

Cash and cash equivalents – end of period
$
3,950

 
$
158,688

 
$
3,273,316

 
$

 
$
3,435,954

____________
(1)
Results for the period include XL-Ireland, which prior to the Redomestication was the ultimate parent and is now in liquidation proceedings as outlined in Note 1, "Significant Accounting Policies." The Company expects the net assets of XL-Ireland to ultimately be distributed to XL Group upon completion of the liquidation.
 
Year Ended December 31, 2016
Condensed Consolidating Statement of Cash Flows
(U.S. dollars in thousands)
XL-Group (1)
 
XLIT
 
Other XL-Group Subsidiaries
 
Consolidating Adjustments and Eliminations
 
XL-Group Consolidated
Cash flows provided by (used in) operating activities:
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
$
978,695

 
$
775,100

 
$
2,145,149

 
$
(2,955,038
)
 
$
943,906

Cash flows provided by (used in) investing activities:
 
 
 
 
 
 
 
 
 
Proceeds from sale of fixed maturities and short-term investments
$

 
$
303,070

 
$
13,037,976

 
$
(583,466
)
 
$
12,757,580

Proceeds from redemption of fixed maturities and short-term investments

 
97,168

 
3,750,541

 

 
3,847,709

Proceeds from sale of equity securities

 

 
848,779

 

 
848,779

Purchases of fixed maturities and short-term investments

 
(534,502
)
 
(15,506,653
)
 
583,466

 
(15,457,689
)
Purchases of equity securities

 

 
(1,103,447
)
 

 
(1,103,447
)
Proceeds from sale of affiliates

 
324

 
396,767

 

 
397,091

Purchases of affiliates

 

 
(681,385
)
 

 
(681,385
)
Purchase of subsidiaries, net of acquired cash

 

 
(92,893
)
 

 
(92,893
)
Proceeds from sale of subsidiary, net of cash sold

 

 
22,998

 

 
22,998

Returns of capital from subsidiaries
274,727

 
465,203

 

 
(739,930
)
 

Change in restricted cash

 

 
1,488

 

 
1,488

Other, net

 

 
197,536

 

 
197,536

Net cash provided by (used in) investing activities
$
274,727

 
$
331,263

 
$
871,707

 
$
(739,930
)
 
$
737,767

Cash flows provided by (used in) financing activities:
 
 
 
 
 
 
 
 
 
Proceeds from issuance of common shares and exercise of stock options
$
9,854

 
$

 
$

 
$

 
$
9,854

Buybacks of common shares
(1,051,050
)
 

 

 

 
(1,051,050
)
Employee withholding on share-based compensation

 

 
(28,569
)
 

 
(28,569
)
Dividends paid on common shares
(222,761
)
 
(1,039,253
)
 
(1,915,785
)
 
2,955,038

 
(222,761
)
Return of capital

 
(274,727
)
 
(465,203
)
 
739,930

 

Distributions to non-controlling interests

 
(78,094
)
 
(52,353
)
 

 
(130,447
)
Contributions from non-controlling interests

 

 
47,524

 

 
47,524

Repayment of debt

 

 
(8,248
)
 

 
(8,248
)
Deposit liabilities

 

 
(69,482
)
 

 
(69,482
)
Net cash provided by (used in) financing activities
$
(1,263,957
)
 
$
(1,392,074
)
 
$
(2,492,116
)
 
$
3,694,968

 
$
(1,453,179
)
Effects of exchange rate changes on foreign currency cash

 

 
(57,742
)
 

 
(57,742
)
Increase (decrease) in cash and cash equivalents
$
(10,535
)
 
$
(285,711
)
 
$
466,998

 
$

 
$
170,752

Cash and cash equivalents – beginning of period
11,557

 
369,997

 
2,874,682

 

 
3,256,236

Cash and cash equivalents – end of period
$
1,022

 
$
84,286

 
$
3,341,680

 
$

 
$
3,426,988


____________
(1)
Results for the period include XL-Ireland, which prior to the Redomestication was the ultimate parent and is now in liquidation proceedings as outlined in Note 1, "Significant Accounting Policies." The Company expects the net assets of XL-Ireland to ultimately be distributed to XL Group upon completion of the liquidation.

 
Year Ended December 31, 2015
Condensed Consolidating Statement of Cash Flows
(U.S. dollars in thousands)
XL- Ireland
 
XLIT
 
Other XL-Ireland Subsidiaries
 
Consolidating Adjustments and Eliminations
 
XL-Ireland Consolidated
Cash flows provided by (used in) operating activities:
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
$
561,468

 
$
148,850

 
$
698,440

 
$
(764,277
)
 
$
644,481

Cash flows provided by (used in) investing activities:
 
 
 
 
 
 
 
 
 
Proceeds from sale of fixed maturities and short-term investments
$

 
$
1,482,875

 
$
15,745,247

 
$
(359,894
)
 
$
16,868,228

Proceeds from redemption of fixed maturities and short-term investments

 
188,788

 
3,562,386

 

 
3,751,174

Proceeds from sale of equity securities

 

 
664,735

 

 
664,735

Purchases of fixed maturities and short-term investments

 
(1,296,980
)
 
(18,780,978
)
 
359,894

 
(19,718,064
)
Purchases of equity securities

 

 
(567,334
)
 

 
(567,334
)
Proceeds from sale of affiliates

 

 
748,575

 

 
748,575

Purchases of affiliates

 

 
(280,856
)
 

 
(280,856
)
Purchase of subsidiaries, net of acquired cash
(2,287,579
)
 
(2,317,699
)
 
1,267,564

 
2,317,699

 
(1,020,015
)
Proceeds from sale of subsidiary, net of cash sold
2,317,699

 

 

 
(2,317,699
)
 

Returns of capital from subsidiaries
65,037

 
2,047,000

 

 
(2,112,037
)
 

Change in restricted cash

 

 
(154,992
)
 

 
(154,992
)
Other, net

 

 
(155,019
)
 

 
(155,019
)
Net cash provided by (used in) investing activities
$
95,157

 
$
103,984

 
$
2,049,328

 
$
(2,112,037
)
 
$
136,432

Cash flows provided by (used in) financing activities:
 
 
 
 
 
 
 
 
 
Proceeds from issuance of common shares and exercise of stock options
$
9,976

 
$

 
$

 
$

 
$
9,976

Buybacks of common shares
(468,971
)
 

 

 

 
(468,971
)
Employee withholding on share-based compensation

 

 
(28,925
)
 

 
(28,925
)
Dividends paid on common shares
(208,516
)
 
(764,277
)
 

 
764,277

 
(208,516
)
Return of capital

 
(65,037
)
 
(2,047,000
)
 
2,112,037

 

Distributions to non-controlling interests

 
(77,093
)
 
(40,590
)
 

 
(117,683
)
Contributions from non-controlling interests

 

 
23,610

 

 
23,610

Proceeds from issuance of debt

 
980,600

 

 

 
980,600

Repayment of debt

 

 
(87,447
)
 

 
(87,447
)
Deposit liabilities

 

 
(84,758
)
 

 
(84,758
)
Net cash provided by (used in) financing activities
$
(667,511
)
 
$
74,193

 
$
(2,265,110
)
 
$
2,876,314

 
$
17,886

Effects of exchange rate changes on foreign currency cash

 

 
(64,377
)
 

 
(64,377
)
Increase (decrease) in cash and cash equivalents
$
(10,886
)
 
$
327,027

 
$
418,281

 
$

 
$
734,422

Cash and cash equivalents – beginning of period
22,443

 
42,970

 
2,456,401

 

 
2,521,814

Cash and cash equivalents – end of period
$
11,557

 
$
369,997

 
$
2,874,682

 
$

 
$
3,256,236